STAT+: Pharmalittle: We’re reading about a new policy for compounding peptides, a PBM disclosure rule, and more

Excerpt from STAT News.

More Stories

Lifestyle

STAT+: Vertex kidney disease drug scrutinized for infection risk

Ahead of its FDA approval decision on Nov 30, Vertex's kidney disease drug is being heavily scrutinized for infection ri…

🇺🇸 STAT News 18m ago

Lifestyle

A single brain signal may explain schizophrenia's most puzzling symptoms

Scientists have identified a weakened brain signal that may connect several seemingly unrelated symptoms of schizophreni…

🇺🇸 ScienceDaily Health 28m ago

Lifestyle

Six popular sugar substitutes linked to faster brain aging

A study of nearly 13,000 adults found that people consuming the most artificial sweeteners experienced a 62% faster decl…

🇺🇸 ScienceDaily Health 39m ago